BIT 5.00% 1.9¢ biotron limited

merck's hcv drug bring's in only $21 million, page-12

  1. 1,860 Posts.
    lightbulb Created with Sketch. 33
    doubling of the MC is conservative - and it all depends on the quality of the results and how quickly a commercial deal is struck off the back of them - I would say 6 - 12 months (i.e. post HIV trial). exciting times.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.